Turning Point Therapeutics Stock Price, News & Analysis
Company Description
Turning Point Therapeutics (NASDAQ: TPTX) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector. The company has a market capitalization of $3.8B.
TPTX stock has gained 13.9% over the past year.
This page provides a comprehensive overview of TPTX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Turning Point Therapeutics (TPTX) stock. Over the past 12 months, the stock has gained 13.9%. At a market capitalization of $3.8B, TPTX is classified as a mid-cap stock with approximately 50.1M shares outstanding.
Latest News
Turning Point Therapeutics has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include acquisition, earnings, conferences, management. View all TPTX news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
TPTX Company Profile & Sector Positioning
Turning Point Therapeutics (TPTX) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.